Warning letter
Muro Pharmaceutical Inc.: warning letter of Feb 16, 2000
FDA warning letter UCM068128 · New England District Office
Key facts
| Reference number | UCM068128 |
|---|---|
| Company | Muro Pharmaceutical Inc. |
| Subject | Finished Pharmaceuticals |
| Issue date | Feb 16, 2000 |
| Posted date | Feb 16, 2000 |
| Issuing office | New England District Office |
| Product type | Drugs |
| Country | 3 |
| Inspection city | Tewksbury |
| Inspection ZIP | 01876-1452 |
| Inspection start date | Jan 18, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: